Pure Global
NCT05976295

Efficacy of Jianpi Qushi Huatan Decoction in the Treatment of Polycystic Ovary Syndrome

Efficacy of Jianpi Qushi Huatan Decoction in the Treatment of Polycystic Ovary Syndrome: A Randomized Double-blind Placebo-controlled Trial
Jiangxi University of Traditional Chinese Medicine·Phase 1/2·ClinicalTrials.gov·drugRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Polycystic Ovary Syndrome
Drug/Device/Intervention
Jianpi Qushi Huatan Decoction
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Jiangxi University of Traditional Chinese Medicine
Location
Nancang, China
Timeline & enrollment
Phase
Phase 1/2
Start date
Sep 01, 2023
End date
Dec 01, 2025
Enrollment
68 participants
Primary outcome

Ovulation rate

Summary

Polycystic ovary syndrome (PCOS) is a common reproductive disease associated with endocrine
 and metabolic disorders. Some studies have shown that Chinese herbal medicine is beneficial
 for PCOS, but the efficacy of Chinese herbal medicine in the treatment of PCOS is not clear,
 because the quantity of pre-clinical data was limited and the quality of clinical evidence
 was variable. Therefore, this randomized double-blind placebo-controlled trial aim to
 evaluate the efficacy of Chinese herbal medicine (Jianpi Qushi Huatan Decoction) in women
 with PCOS.

ICD-10 classifications
Polycystic ovarian syndromeOvarian dysfunction, unspecifiedOvarian dysfunctionOther ovarian dysfunctionNeoplasm of uncertain or unknown behaviour: Ovary
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05976295
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05976295 through Pure Global AI's free database. This Phase 1/2 trial is sponsored by Jiangxi University of Traditional Chinese Medicine and is currently Recruiting. The study focuses on Polycystic Ovary Syndrome. Target enrollment is 68 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.